From: Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
Power analysis
CRP reduction
(estimated mean 7.64Â mg/l)
N = 28
50%
55%
60%
65%
70%
75%
SD 3.37Â mg/l
85%
91%
95%
97%
99%
 > 99%
SD 3.74Â mg/l
77%
84%
90%
94%
98%
SD 4.11Â mg/l
69%
89%
93%
96%